Researchers Create Modified Antibodies to Target RAS and p53 in Cancer

Researchers Create Modified Antibodies to Target RAS and p53 in Cancer

SEMrush
Researchers have developed synthetic antibodies, called diabodies, that block the activity of two of the most notorious cancer-related proteins, RAS and p53. In experiments in mice, the synthetic antibodies shrank tumors with these mutated proteins.
[automaticbacklinks]